Publisher credits his work interpreting how innovation, entrepreneurship, and capital converge to reshape modern industries Baltimore, MD, Feb. 20, 2026…
Olanzapine long-acting injectable (LAI) suspension (TEV-‘749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1…